Gopi Shankar is Chief Development Officer at Larimar Therapeutics, Inc. (LRMR). They have made 1 open-market trade across 1 company since 2023, most recently 2026-01-26.
CIK 0001965014
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $19K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LRMR | 76,443 | $152K |
Shares reported on the most recent Form 4, priced at the 2026-01-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LRMR | BUY | 2023-12-07 | 2023-12-08 | $3.73 | $19K | +10.0% | +30.4% | +212.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.